Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Vermillion to Present Corporate Overview at the Canaccord Genuity Medical Technology and Diagnostic Forum
-
Vermillion to Present Corporate Overview at the Canaccord Genuity 36th Annual Growth Conference
-
Canaccord Genuity Reiterates Buy on Vermillion (VRML) Following FDA Clearance for Overa
-
Vermillion to Present Corporate Overview at the Canaccord Genuity Medical Technology & Diagnostics Forum
-
Notable Analyst Rating Changes 8/11: (ADBE) (RAX) (VZ) Upgraded; (AMAT) (KMT) (XON) Downgraded
-
Canaccord Genuity Starts Vermillion (VRML) at Buy
-
Vermillion, Inc. Announces Closing of $18.8 Million Public Offering of Common Stock
-
Vermillion (VRML) Prices 8.35M Common Stock Offering at $1.96/Share
-
Vermillion, Inc. Prices $16.4 Million Public Offering of Common Stock
-
Vermillion (VRML) Plans Public Offering of Common Stock
-
Vermillion, Inc. Announces Proposed Public Offering of Common Stock

